Clinical Trials at Mount Sinai Comprehensive Cancer Center at Aventura
As of August 2026, 16 paid clinical trials are recruiting at Mount Sinai Comprehensive Cancer Center at Aventura, located at Mount Sinai Comprehensive Cancer, 2845 NE 199th St #243, Miami, FL 33180, phone (305) 692-5400 in Aventura, Florida. Active studies at this site cover conditions such as Anatomic Stage IV Breast Cancer AJCC v8, Alzheimer's Disease and Malignant Solid Neoplasm. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
16 clinical trials at Mount Sinai Comprehensive Cancer Center at Aventura
·Clear filters·Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Common conditions studied in Aventura
- Anatomic Stage IV Breast Cancer AJCC v8 (5 active studies)
- Alzheimer's Disease (4 active studies)
- Malignant Solid Neoplasm (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
- Actinic Keratosis (2 active studies)
- Acute Myeloid Leukemia (2 active studies)
Leading research sponsors in Aventura
- National Cancer Institute (NCI)
- NRG Oncology
- SWOG Cancer Research Network
- ACADIA Pharmaceuticals Inc.
- Amgen
Frequently asked questions
How many paid clinical trials are currently recruiting in Aventura?
There are approximately 82 recruiting clinical trials in Aventura, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Aventura pay participants?
Most recruiting trials in Aventura compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Aventura?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Aventura?
The most common conditions under active study in Aventura include Anatomic Stage IV Breast Cancer AJCC v8 (5), Alzheimer's Disease (4), Malignant Solid Neoplasm (3), Stage IV Lung Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Aventura?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Aventura on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Aventura?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Aventura?
Recruiting research sites in Aventura include Mount Sinai Comprehensive Cancer Center at Aventura, UM Sylvester Comprehensive Cancer Center at Aventura, Center for Clinical and Cosmetic Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Aventura right now?
The largest active categories in Aventura are Cancer & tumors (38), Neurology & pain (4), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Mount Sinai Comprehensive Cancer Center at Aventura?
Mount Sinai Comprehensive Cancer Center at Aventura is located at Mount Sinai Comprehensive Cancer, 2845 NE 199th St #243, Miami, FL 33180. Use the Google Maps link in the intro above to get directions.
How do I contact Mount Sinai Comprehensive Cancer Center at Aventura?
You can reach Mount Sinai Comprehensive Cancer Center at Aventura by phone at (305) 692-5400. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.